Watch Ticker

Genelux Corporation Common Stock

Go to Genelux Corporation Common Stock Website

$3.53

0.02 (0.57%)
Live
Previous Close

$3.51

Day Range

$3.475 - $3.58

Previous Day Range

$3.41 - $3.615

Market Cap

$132.5 million USD

Day Vol.

91728

Previous Day Vol.

139024

Currency

USD

Primary Exchange

Nasdaq

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Genelux Corporation, a late clinical-stage immuno-oncology company, announced that its President, Chairman and CEO will discuss the company's clinical-stage programs, recent announcements, and upcoming milestones at the H.C. Wainwright Global Healthcare Conference.

Related tickers: GNLX.

Read Full Article

Genelux Corporation, a late clinical-stage immuno-oncology company, announced that its President, CEO and Chairman will discuss the company's clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at BTIG's Virtual Biotechnology Conference 2024.

Related tickers: GNLX.

Read Full Article
Trending Tickers

Please sign in to view